Zelira Therapeutics Limited filed its Annual on Aug 31, 2022 for the period ending Jun 30, 2022. In this report its auditor, Hlb Mann Judd, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.715 AUD | +1.42% | +3.62% | -20.56% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.56% | 5.22M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.76% | 22.15B | |
-17.37% | 21.02B | |
-8.35% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Limited Auditor Raises 'Going Concern' Doubt